Chihara, Dai

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Stein-Thoeringer, C. K., Saini, N. Y., Zamir, E., Blumenberg, V., Schubert, M.-L., Mor, U., Fante, M. A., Schmidt, S., Hayase, E., Hayase, T., et al. (2023) · Nature Medicine

CAR-T cell therapy researchGut microbiota and health

Cited by 255

Recent advances in the treatment of adult T‐cell leukemia‐lymphomas

Utsunomiya, A., Choi, I., Chihara, D., & Seto, M. (2015) · Cancer Science

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 103

Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis

Chihara, D., Masarova, L., Newberry, K. J., Maeng, H., Ravandi, F., Garcia-Manero, G., Ferrajoli, A., Cortes, J., Kantarjian, H., & Verstovsek, S. (2016) · Leukemia Research

Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 21